Formycon Files Aflibercept With US FDA

Klinge And Coherus Are US Partners For FYB203 Biosimilar Rival To Eylea

 
• By Dave Wallace
  
US flag reflected in eye
Formycon has filed its second ophthalmic biosimilar in the US • Source: Shutterstock

More from Biosimilars

More from Products